Company insider dossier

Nephros Inc insider intelligence

NEPH filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Medical Instruments & Supplies Data API
72/100

Conviction accumulation

40/100 confidence
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Instruments & Supplies
Latest evidence
18 Aug 2026

Investment committee read

Conviction accumulation

Priced common-share acquisitions carry more weighted evidence than disposals after freshness, role, size, and duplicate controls.

Research constructive setups

Evidence in favour

  • The latest qualifying evidence is fresh, dated 18 Aug 2026.

Decision risks

  • Reported purpose is unavailable in this feed, so even priced common-share transactions need filing context.
Conviction72Conviction accumulation
Confidence40Thin evidence
Named insiders2participating in the tape
Controlled events1directional common-share events
Acquisition value$2.9Knormalized amount
Disposal value$0normalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

5.704.663.622.591.55 Acquisition · 18 Aug 2026 · $2.9KAcquisition · 12 Aug 2026 · Not reportedAcquisition · 11 May 2026 · Not reported
Mar 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
4.55 USD
One-week move
+11.5%
Four-week move
+34.2%
Fair-value gap
+57.5%
Trend signal
Active
Relative strength
-0.7

Directional balance

Controlled event mix

100.0%acquisition
Acquisition events
1
Disposal events
0
Net value
$2.9K

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

008 Jun
015 Jun
022 Jun
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
110 Aug
217 Aug
024 Aug

Named participants

Insider conviction by person

WEXFORD, CAPITAL LP10% Owner721 events
AMRON, ARTHUR HDirector500 events

Evidence quality

Security and transaction context

Common equity3
Equity compensation0
Options and derivatives1
Other securities0

Role architecture

Who is participating

Director2
Large holder2

Transaction evidence

Auditable NEPH filing ledger

Showing 1 to 4 of 4.

WEXFORD, CAPITAL LP10% Owner
DisposalOptions and derivatives
3765 sharesStock Option (Right to Buy)
Not reportedContext evidence
WEXFORD, CAPITAL LP10% Owner
AcquisitionCommon equity
812 sharesCommon Stock
$2.9KDirectional evidence
AMRON, ARTHUR HDirector
AcquisitionCommon equity
2418 sharesCommon Stock
Not reportedContext evidence
AMRON, ARTHUR HDirector
AcquisitionCommon equity
3574 sharesCommon Stock
Not reportedContext evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context